Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Fundació Institució Catalanà De Recerca I Estudis Avançats operates in the Biotechnology & Pharmaceuticals technology area. The company currently has 2 pending office actions. Both of these actions are being reviewed by 1 distinct examiner, SINGH, ANOOP KUMAR.
The portfolio is associated with 1 distinct art unit. SINGH, ANOOP KUMAR is the busiest examiner for the company, with 2 busiest examiner pending office actions. This shows a concentrated prosecution effort where a single examiner is responsible for all active matters in the biotechnology and pharmaceutical space.
For practitioners, the presence of 2 pending office actions under 1 examiner in 1 art unit suggests a very focused intellectual property strategy. This concentration allows for a consistent dialogue with the examiner across multiple filings. The company's innovations are currently being examined by a single point of contact at the patent office, simplifying the management of the pending matters and ensuring a uniform approach to the firm's pharmaceutical research.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 2 | 43.2% | +67.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18773164 | SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS | SINGH, ANOOP KUMAR | — |
| 18773181 | SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS | SINGH, ANOOP KUMAR | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18773164 | SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS | SINGH, ANOOP KUMAR | 1632 | §103§112DP | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18773181 | SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND BEHAVIOUR IMPAIRMENTS | SINGH, ANOOP KUMAR | 1632 | §102§103DP | Non-Final OA | — | Pending | Jul 15, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundació Institució Catalanà De Recerca I Estudis Avançats has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Anoop Kumar Singh has the most, with 2 of Fundació Institució Catalanà De Recerca I Estudis Avançats's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
